Intech Biopharm Corporation (TPEX:6461)
Taiwan · Delayed Price · Currency is TWD 19.20
+0.05 (0.26%)
Aug 15, 2025, 1:30 PM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 3.13 billion as of August 15, 2025. Its market cap has decreased by -23.98% in one year.
Market Cap
3.13B
Enterprise Value
4.10B
Revenue
115.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.20
Market Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 3.13B, a decrease of -21.88%. That is a compound annual growth rate of -2.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 3.13B | -14.09% |
| Dec 31, 2024 | 3.64B | -11.36% |
| Dec 29, 2023 | 4.11B | 5.65% |
| Dec 30, 2022 | 3.89B | 67.22% |
| Dec 30, 2021 | 2.33B | 11.52% |
| Dec 31, 2020 | 2.09B | 40.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 208.61B |
| PharmaEssentia | 169.30B |
| Bora Pharmaceuticals Co., LTD. | 94.94B |
| Lotus Pharmaceutical | 53.91B |
| Oneness Biotech | 32.23B |
| Polaris Group | 27.62B |
| Lumosa Therapeutics | 27.18B |
| Center Laboratories | 26.85B |